is glp 1 banned by wada Weight Loss Drugs: What athletes need to know about GLP-1s GLP-1 and WADA: Is Semaglutide
Description
PRAC is assessing whether patients treated with semaglutide may have an elevated risk of developing NAION
Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control
Obesity is a known risk factor for HS
Your provider will determine the most appropriate treatment options based on current medical guidelines, clinical evidence, and your individual health profile
J., Benoit S
However, Sermorelin excels in promoting long-term metabolic improvements, which may lead to sustainable benefits over time
